HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

B&K CORP-B

4.380

-0.015-0.34%

Volume:51.40K

Turnover:204.57K

Market Cap:515.34M

PE:-2.11

High:4.495

Open:3.855

Low:3.830

Close:4.395

52wk High:37.200

52wk Low:3.500

Shares:117.66M

HK Float Shares:83.02M

Volume Ratio:4.15

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-2.080

ROE:-53.92%

ROA:-29.66%

PB:0.79

PE(LYR):-2.11

PS:844.57

Loading ...

Overview Company News Filings

Companies Like B&K (HKG:2396) Are In A Position To Invest In Growth

Simply Wall St.

B&K Corp shareholders approve share issue mandate at AGM

B&K Corp Schedules 22 June 2026 AGM; Seeks Name Change, 20% Issuance & 10% Buyback Mandates, No 2025 Dividend

Bulletin Express

B&K Corporation Enrolls Patient in Phase 3a Clinical Trial of Burns Drug

MT Newswires Live

B&K Corp Begins Phase IIIa Trial of Core Burn-Treatment Candidate Pro-101-1 with First Patient Enrollment

Bulletin Express

B&K CORP-B (02396) Achieves First Patient Enrollment in Phase IIIa Trial for Pro-101-1 in Deep Second-Degree Burn Treatment

B&K enrolls first patient in Phase IIIa Pro-101-1 deep second-degree burns trial

B&K CORP-B Reports Stable Share Structure and Confirms Public Float Compliance for April 2026

Bulletin Express

B&K Corporation releases 2025 ESG report

B&K Corp publishes 2025 annual report

B&K CORP-B年报：营收翻倍至5.22亿元，研发持续投入助推PDGF核心产品临床推进

Bulletin Express

B&K Corp. Plans Articles Overhaul and Abolition of Supervisory Committee

Bulletin Express

B&K proposes bylaw amendments to abolish supervisory committee

B&K CORP-B Reports No Share Capital Changes in March 2026; Confirms Public Float Compliance

Bulletin Express

B&K CORP-B Reports Annual Financial Results with Narrowed Net Loss

B&K CORP-B (02396) sets 30 Mar 2026 board meeting to review FY2025 results and dividend proposal

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/02396/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02396","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02396\",,,,,undefined,":{"symbol":"02396","market":"HK","secType":"STK","nameCN":"B&K CORP-B","latestPrice":4.38,"timestamp":1789027138366,"preClose":4.395,"halted":0,"volume":51400,"delay":0,"changeRate":-0.003412969283276378,"floatShares":83022145,"shares":117657522,"eps":-2.08,"marketStatus":"Closed","change":-0.015,"latestTime":"09-10 15:58:58","open":3.855,"high":4.495,"low":3.83,"amount":204566,"amplitude":0.151308,"askPrice":4.38,"askSize":1000,"bidPrice":3.95,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-2.39,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1766332800000,"exchange":"SEHK","adjPreClose":4.395,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":4.145161,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02396\",,,,,undefined,":{"symbol":"02396","floatShares":83022145,"roa":"-29.66%","roe":"-53.92%","lyrEps":-2.08,"volumeRatio":4.145161,"shares":117657522,"dividePrice":0,"high":4.495,"amplitude":0.151308,"preClose":4.395,"low":3.83,"week52Low":3.5,"pbRate":"0.79","psRate":"844.57","week52High":37.2,"institutionHeld":0,"latestPrice":4.38,"eps":-2.08,"divideRate":0,"volume":51400,"delay":0,"ttmEps":-2.39,"open":3.855,"prevYearClose":16.17,"prevWeekClose":4.6,"prevMonthClose":4.88,"prevQuarterClose":4.08,"fiveDayClose":4.7,"twentyDayClose":3.88,"sixtyDayClose":4.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02396\",params:#limit:5,,,undefined,":[{"date":"2026-08-14","symbol":"02396","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786671000000,"name":null,"time":"","dateTimestamp":1786636800000,"actualEps":null},{"date":"2026-03-30","symbol":"02396","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02396\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02396\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02396\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02396","date":"2026-09-09","current":-1.832636,"percent":0.948276,"low":-22.370893,"twenty":-5.319907,"median":-2.5236,"eighty":-1.896784,"high":-1.762187,"avg":-3.831293,"sd":2.721771,"marketCap":517104809},"quantilePoints":[{"date":"2025-12-19","current":-22.370893,"twenty":-22.370893,"median":-22.370893,"eighty":-22.370893,"marketCap":5247525481},{"date":"2025-12-24","current":-12.774079,"twenty":-17.071319,"median":-13.156175,"eighty":-12.763931,"marketCap":2586112333},{"date":"2026-01-02","current":-9.273817,"twenty":-13.232594,"median":-12.516848,"eighty":-9.766713,"marketCap":1884873502},{"date":"2026-01-09","current":-7.148857,"twenty":-12.763931,"median":-9.361922,"eighty":-7.100351,"marketCap":1456600122},{"date":"2026-01-16","current":-6.722795,"twenty":-12.56322,"median":-7.752698,"eighty":-6.987427,"marketCap":1374239856},{"date":"2026-01-23","current":-6.1704,"twenty":-11.520552,"median":-7.202103,"eighty":-6.484159,"marketCap":1260112060},{"date":"2026-01-30","current":-5.620424,"twenty":-9.969109,"median":-7.000858,"eighty":-6.122005,"marketCap":1153043715},{"date":"2026-02-06","current":-5.074187,"twenty":-9.32668,"median":-6.831002,"eighty":-5.802397,"marketCap":1043622220},{"date":"2026-02-13","current":-5.289789,"twenty":-8.733132,"median":-6.318622,"eighty":-5.490299,"marketCap":1094214954},{"date":"2026-02-20","current":-5.314508,"twenty":-8.192447,"median":-6.303522,"eighty":-5.373181,"marketCap":1097744680},{"date":"2026-02-27","current":-5.239953,"twenty":-7.651053,"median":-6.089741,"eighty":-5.311704,"marketCap":1094214954},{"date":"2026-03-06","current":-4.96445,"twenty":-7.41652,"median":-5.866722,"eighty":-5.258632,"marketCap":1028326742},{"date":"2026-03-13","current":-4.540249,"twenty":-7.236648,"median":-5.782264,"eighty":-5.14321,"marketCap":944789901},{"date":"2026-03-20","current":-4.296428,"twenty":-7.159506,"median":-5.556529,"eighty":-5.006513,"marketCap":890667441},{"date":"2026-03-27","current":-4.125305,"twenty":-7.084183,"median":-5.376979,"eighty":-4.752904,"marketCap":853017034},{"date":"2026-04-02","current":-4.190517,"twenty":-6.987427,"median":-5.341502,"eighty":-4.651676,"marketCap":870665662},{"date":"2026-04-10","current":-4.209019,"twenty":-6.916847,"median":-5.307499,"eighty":-4.524615,"marketCap":881254839},{"date":"2026-04-17","current":-4.207253,"twenty":-6.845738,"median":-5.289789,"eighty":-4.24209,"marketCap":881254839},{"date":"2026-04-24","current":-2.580199,"twenty":-6.809361,"median":-5.233134,"eighty":-4.158607,"marketCap":618514980},{"date":"2026-04-30","current":-2.370918,"twenty":-6.722795,"median":-5.166911,"eighty":-4.112803,"marketCap":568701693},{"date":"2026-05-08","current":-1.990933,"twenty":-6.325068,"median":-5.074187,"eighty":-4.070121,"marketCap":479037776},{"date":"2026-05-15","current":-1.944413,"twenty":-6.312176,"median":-4.99074,"eighty":-4.003624,"marketCap":469075119},{"date":"2026-05-22","current":-1.869532,"twenty":-6.294869,"median":-4.801286,"eighty":-2.572587,"marketCap":449980025},{"date":"2026-05-29","current":-2.406462,"twenty":-6.195294,"median":-4.744727,"eighty":-2.47593,"marketCap":581228158},{"date":"2026-06-05","current":-2.524582,"twenty":-6.105873,"median":-4.639702,"eighty":-2.50499,"marketCap":610642539},{"date":"2026-06-12","current":-2.336454,"twenty":-6.04436,"median":-4.520707,"eighty":-2.447556,"marketCap":564756105},{"date":"2026-06-18","current":-2.18581,"twenty":-5.937353,"median":-4.327355,"eighty":-2.373779,"marketCap":529458849},{"date":"2026-06-26","current":-2.039753,"twenty":-5.865351,"median":-4.218762,"eighty":-2.296626,"marketCap":491808441},{"date":"2026-07-03","current":-2.096742,"twenty":-5.856594,"median":-4.198885,"eighty":-2.202961,"marketCap":505927344},{"date":"2026-07-10","current":-1.78198,"twenty":-5.823918,"median":-4.125305,"eighty":-2.10196,"marketCap":429449955},{"date":"2026-07-17","current":-1.829174,"twenty":-5.777173,"median":-4.108105,"eighty":-2.059285,"marketCap":442392282},{"date":"2026-07-24","current":-1.896855,"twenty":-5.709892,"median":-4.095167,"eighty":-2.009543,"marketCap":458864335},{"date":"2026-07-31","current":-1.762187,"twenty":-5.594866,"median":-4.054956,"eighty":-1.985679,"marketCap":427096804},{"date":"2026-08-07","current":-1.865363,"twenty":-5.474817,"median":-4.009947,"eighty":-1.920991,"marketCap":452981459},{"date":"2026-08-14","current":-1.8872,"twenty":-5.398235,"median":-2.580199,"eighty":-1.89994,"marketCap":458864335},{"date":"2026-08-21","current":-2.708337,"twenty":-5.373181,"median":-2.575598,"eighty":-1.89994,"marketCap":771245056},{"date":"2026-08-28","current":-2.015818,"twenty":-5.354692,"median":-2.542127,"eighty":-1.905189,"marketCap":574168707},{"date":"2026-09-04","current":-1.899394,"twenty":-5.336103,"median":-2.526416,"eighty":-1.8992,"marketCap":541224601},{"date":"2026-09-09","current":-1.812324,"twenty":-5.319907,"median":-2.5236,"eighty":-1.896784,"marketCap":517104809}],"updateTime":1789041810748},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02396\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647581864","title":"Companies Like B&K (HKG:2396) Are In A Position To Invest In Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2647581864","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647581864?lang=en_us&edition=fundamental","pubTime":"2026-06-30 08:41","pubTimestamp":1782780084,"startTime":"0","endTime":"0","summary":"Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2396/bk-shares/news/companies-like-bk-hkg2396-are-in-a-position-to-invest-in-gro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2396/bk-shares/news/companies-like-bk-hkg2396-are-in-a-position-to-invest-in-gro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645786040","title":"B&K Corp shareholders approve share issue mandate at AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=2645786040","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645786040?lang=en_us&edition=fundamental","pubTime":"2026-06-22 22:05","pubTimestamp":1782137136,"startTime":"0","endTime":"0","summary":"B&K held its annual general meeting on June 22, 2026.Shareholders adopted the 2025 directors’ report, supervisory committee work report, board work report, annual report, audited financial statements.Ernst & Young was reappointed as auditor; the board was authorized to set its remuneration.A profit distribution plan for 2025 was adopted; amendments were approved to the rules for general meetings, board meetings.Special resolutions passed to grant an issue mandate, approve an H-share repurchase mandate, change the company name, amend the articles, abolish the supervisory committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. B&K Corporation Limited published the original content used to generate this news brief via IIS, the regulator","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL8zTNw2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195082438","title":"B&K Corp Schedules 22 June 2026 AGM; Seeks Name Change, 20% Issuance & 10% Buyback Mandates, No 2025 Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=1195082438","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195082438?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:03","pubTimestamp":1780052589,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited (B&K Corp) will hold its 2025 annual general meeting on 22 June 2026 at the Metropark Hotel Yingkun Beijing.  Shareholders on record as of the close of business 22 June 2026...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635739042","title":"B&K Corporation Enrolls Patient in Phase 3a Clinical Trial of Burns Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2635739042","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635739042?lang=en_us&edition=fundamental","pubTime":"2026-05-13 11:21","pubTimestamp":1778642516,"startTime":"0","endTime":"0","summary":"B&K Corporation  said it enrolled the first patient in the phase 3a clinical trial of Pro-101-1 to treat deep second-degree burns, according to a Tuesday filing with the Hong Kong bourse.The biopharmaceutical company shares fell 1% in morning trade Wednesday.Pro-101-1 is one of the core products of the company.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02396","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197970022","title":"B&K Corp Begins Phase IIIa Trial of Core Burn-Treatment Candidate Pro-101-1 with First Patient Enrollment","url":"https://stock-news.laohu8.com/highlight/detail?id=1197970022","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197970022?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:23","pubTimestamp":1778592180,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited (B&K Corp) has enrolled the first patient in its Phase IIIa clinical trial of Pro-101-1, a recombinant human platelet-derived growth factor BB (rhPDGF-BB) gel under...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167182587","title":"B&K CORP-B (02396) Achieves First Patient Enrollment in Phase IIIa Trial for Pro-101-1 in Deep Second-Degree Burn Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1167182587","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167182587?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:20","pubTimestamp":1778592020,"startTime":"0","endTime":"0","summary":"B&K CORP-B (02396) has announced that the Phase IIIa clinical trial for Pro-101-1, a product developed by the company for the treatment of deep second-degree burns, has recently completed enrollment...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634021405","title":"B&K enrolls first patient in Phase IIIa Pro-101-1 deep second-degree burns trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2634021405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634021405?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:12","pubTimestamp":1778591537,"startTime":"0","endTime":"0","summary":"B&K Corporation flagged first patient enrollment in Phase IIIa trial of Pro-101-1 for deep second-degree burns, marking start of pivotal-stage clinical testing.No results have been presented yet; trial is designed to assess whether rhPDGF-BB gel can improve healing outcomes while maintaining an acceptable safety profile.Study uses randomized, double-blind, placebo-controlled design to generate parameters intended to support planning for a subsequent Phase IIIb trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. B&K Corporation Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 12, 2026, and is solely responsible for the inf","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL6sxltL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139014834","title":"B&K CORP-B Reports Stable Share Structure and Confirms Public Float Compliance for April 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1139014834","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139014834?lang=en_us&edition=fundamental","pubTime":"2026-05-06 17:23","pubTimestamp":1778059427,"startTime":"0","endTime":"0","summary":"B&K CORPORATION LIMITED (B&K CORP-B) released its monthly return for the period ended 30 April 2026, indicating no changes in registered or issued share capital during the month. Registered Share...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513851","title":"B&K Corporation releases 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513851","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631513851?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:19","pubTimestamp":1777461576,"startTime":"0","endTime":"0","summary":"B&K Corporation released its FY2025 ESG report, outlining governance oversight for ESG strategy and climate risk management through a board-led framework.R&D spending totaled RMB 89.4 million, with clinical research progress cited for core product PDGF.Scope 1 greenhouse gas emissions were 4.3 tCO2e, with Scope 2 emissions at 163.6 tCO2e.Total energy consumption reached 321.24 MWh, with purchased electricity at 308.32 MWh.Medical waste totaled 1.81 metric tons, with non-hazardous waste at 3.75 metric tons.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. B&K Corporation Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 29, 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL79fd2X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513861","title":"B&K Corp publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513861","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631513861?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:16","pubTimestamp":1777461365,"startTime":"0","endTime":"0","summary":"B&K Corporation issued annual report for year ended Dec. 31, 2025, highlighting progress toward commercialization of PDGF-based wound-healing therapies.Core burn candidate Pro-101-1 completed Phase IIb trial for deep second-degree burns; Phase IIIa study in China moved into active preparation, with launch meeting completed in 2026Q1.Diabetic foot ulcer candidate Pro-101-2 continued Phase II trial in China; patient enrollment accelerated, with target to complete recruitment in first half of 2026.Pipeline expansion advanced, with China IND clearance obtained on March 19, 2026 for Pro-101-3 studies in fresh wounds, pressure ulcers, and chronic radiation ulcers.International development planning continued, with U.S. FDA IND submission for Pro-101-1 Phase III targeted for 2026Q1; Japan PMDA consultation planned for 2026Q3.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nNDL35RK5Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174173676","title":"B&K CORP-B年报：营收翻倍至5.22亿元，研发持续投入助推PDGF核心产品临床推进","url":"https://stock-news.laohu8.com/highlight/detail?id=1174173676","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174173676?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:10","pubTimestamp":1777461015,"startTime":"0","endTime":"0","summary":"B&K...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"B&K CORP-B年报：营收翻倍至5.22亿元，研发持续投入助推PDGF核心产品临床推进","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198464268","title":"B&K Corp. Plans Articles Overhaul and Abolition of Supervisory Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1198464268","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198464268?lang=en_us&edition=fundamental","pubTime":"2026-04-17 21:44","pubTimestamp":1776433452,"startTime":"0","endTime":"0","summary":"B&K Corporation Limited announced a proposal to revise its Articles of Association, chiefly to align with updated PRC company regulations and to strengthen corporate governance. Key changes:   1....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628820170","title":"B&K proposes bylaw amendments to abolish supervisory committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2628820170","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628820170?lang=en_us&edition=fundamental","pubTime":"2026-04-17 21:27","pubTimestamp":1776432429,"startTime":"0","endTime":"0","summary":"B&K Corporation flagged planned amendments to its articles of association to align with updated PRC corporate governance rules.Changes include scrapping supervisory committee structure, shifting its oversight duties to board audit committee.Implementation also requires any necessary filings or clearances with relevant authorities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. B&K Corporation Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDL2pWKXM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165673751","title":"B&K CORP-B Reports No Share Capital Changes in March 2026; Confirms Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1165673751","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165673751?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:04","pubTimestamp":1775732675,"startTime":"0","endTime":"0","summary":"For the month ended 31 March 2026, B&K CORP-B (B&K Corporation Limited) reported unchanged share capital and confirmed adherence to Hong Kong’s minimum public-float requirements, according to its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111338656","title":"B&K CORP-B Reports Annual Financial Results with Narrowed Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1111338656","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111338656?lang=en_us&edition=fundamental","pubTime":"2026-03-30 22:20","pubTimestamp":1774880419,"startTime":"0","endTime":"0","summary":"B&K CORP-B (02396) announced its financial results for the year ended December 31, 2025. The group recorded revenue of 522,000 yuan, representing a 100% increase compared to the previous year. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02396"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107772969","title":"B&K CORP-B (02396) sets 30 Mar 2026 board meeting to review FY2025 results and dividend proposal","url":"https://stock-news.laohu8.com/highlight/detail?id=1107772969","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107772969?lang=en_us&edition=fundamental","pubTime":"2026-03-18 18:03","pubTimestamp":1773828204,"startTime":"0","endTime":"0","summary":"Hong Kong—B&K Corporation Limited (B&K CORP-B; stock code 02396) has scheduled a board meeting for 30 March 2026 in Qingdao, China. According to the company’s announcement, the agenda will focus on...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02396"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":36,"code":"91000000","status":"200"}]}}